AbbVie Collaborates with Global Health Authorities to Investigate its Kaletra/Aluvia (lopinavir/ritonavir) Against COVID-19
Shots:
- AbbVie collaborates with global health authorities- including the FDA- CDC- BARDA- NIH- EU health authorities and Chinese officials to determine the safety & efficacy of Kaletra/Aluvia against COVID-19
- AbbVie donated Aluvia to the Chinese government for experimental use against COVID-19 and has joined the Innovative Medicines Initiative to support research and discovery of therapies against COVID-19
- AbbVie is actively evaluating the increased demand for Kaletra/Aluvia and has taken steps to improve supply for COVID-19 patients without impacting treatment supply for HIV patients
Click here to read full press release/ article
Ref: AbbVie | Image: abbvie
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com